Body mass index and mortality among Japanese patients with type 2 diabetes: Pooled analysis of the Japan diabetes complications study and the Japanese elderly diabetes intervention trial

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 12, 2014, Pages E2692-E2696

  Tanaka, Shiro ^a   Tanaka, Sachiko ^a   Iimuro, Satoshi ^b   Akanuma, Yasuo ^c   Ohashi, Yasuo ^b   Yamada, Nobuhiro ^d   Araki, Atsushi ^e   Ito, Hideki ^e   Sone, Hirohito ^f  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c INSTITUTE FOR ADULT DISEASES   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e Tokyo Metropolitan Institute of Gerontology   (Japan)

^f NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; JAPANESE (PEOPLE); LEISURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; AGED; BIOASSAY; COHORT ANALYSIS; DIABETES MELLITUS; EPIDEMIOLOGY; JAPAN; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84916637440     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1855     Document Type: Article

References (19)

1. The Japan Diabetes Society. Evidence-Based Practice Guideline for the Treatment of Diabetes in Japan. Tokyo: Nankodo Co, Ltd Press; 2010.
2. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33(suppl 1):S11-S61.
3. Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308:581-590.
4. Logue J, Walker JJ, Leese G, et al. Scottish Diabetes Research Network Epidemiology Group. Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care. 2013;36:887-893.
5. Tobias DK, Pan A, Jackson CL, et al. Body mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370:233-244.
6. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
7. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129-2140.
8. Sone H, Ito H, Ohashi Y, Akanuma Y, Yamada N. Japan Diabetes Complication Study Group. Obesity and type 2 diabetes in Japanese patients. Lancet. 2003;361:85.
9. Tanaka S, Tanaka S, Iimuro S, et al. Japan Diabetes Complications Study Group Japanese Elderly Diabetes Intervention Trial Group. Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine. Diabetes Care. 2013;36:1193-1199.
10. Sone H, Tanaka S, Iimuro S, et al. Japan Diabetes Complications Study Group. Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia. 2010;53:419-428.
11. Tanaka S, Tanaka S, Iimuro S, et al, on behalf of the Japan Diabetes Complications Study Group. Cohort profile: the Japan Diabetes Complications Study: a long-term follow-up of a randomised lifestyle intervention study of type 2 diabetes. Int J Epidemiol. 2014;43(4):1054-1062.
12. Araki A, Iimuro S, Sakurai T, et al. Japanese Elderly Diabetes Intervention Trial Study Group. Long-term multiple risk factor interventions in Japanese elderly diabetic patients: the Japanese Elderly Diabetes Intervention Trial-study design, baseline characteristics and effects of intervention. Geriatr Gerontol Int. 2012;12(suppl 1):7-17.
13. Ministry of Health, Labour, and Welfare, Japan. The National Health and Nutrition Survey in Japan 2012. http://www.mhlw.go.jp/file/04-Houdouhappyou-10904750-Kenkoukyoku-Gantaisakukenkouzoushinka/0000032813.pdf (in Japanese). Accessed May 29, 2014.
14. Tseng CH. Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus. Atherosclerosis. 2013;226:186-192.
15. Yano Y, Kario K, Ishikawa S, et al. Jichi Medical School Cohort Study Group. Associations between diabetes, leanness, and the risk of death in the Japanese general population: the Jichi Medical School Cohort Study. Diabetes Care. 2013;36:1186-1192.
16. Ma SH, Park BY, Yang JJ, et al. Interaction of body mass index and diabetes as modifiers of cardiovascular mortality in a cohort study. J Prev Med Public Health. 2012;45:394-401.
17. Friedman GD. Editorial: body mass index and risk of death. Am J Epidemiol. 2014;180(3):233-234, published online.
18. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr. 2007;86(2):353-359.
19. McNeely MJ, Shofer JB, Leonetti DL, Fujimoto WY, Boyko EJ. Associations among visceral fat, all-cause mortality, and obesity-related mortality in Japanese Americans. Diabetes Care. 2012;35(2):296-298.